Keyphrases
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
100%
Comorbidity
36%
Confidence Interval
18%
Cox Proportional Hazards Modeling
9%
Eastern Cooperative Oncology Group Performance Status (ECOG PS)
9%
High-dose Therapy
100%
Low Mortality
9%
Median Overall Survival
9%
Multiple Myeloma
100%
Newly Diagnosed multiple Myeloma
9%
Nontransplant
9%
Older Adults
100%
Overall Survival
18%
Performance Status
27%
Randomized Trial
9%
Salmon
9%
School of Medicine
9%
University of Washington
9%
University Schools
9%
Medicine and Dentistry
Comorbidity
36%
Drug Megadose
100%
Medicine
9%
Multiple Myeloma
100%
Oncology
9%
Overall Survival
27%
Stem Cell Transplant
100%
Transplantation
9%
Immunology and Microbiology
Comorbidity
36%
Drug Megadose
100%
Multiple Myeloma
100%
Overall Survival
27%
Salmon
9%
Salmonine
9%
Stem Cell Transplant
100%
Biochemistry, Genetics and Molecular Biology
Comorbidity
36%
Drug Megadose
100%
Overall Survival
27%
Salmon
9%
Salmonine
9%
Stem Cell Transplant
100%